HealthEquity (NASDAQ:HQY) Sets New 1-Year High – Here’s What Happened

HealthEquity, Inc. (NASDAQ:HQY) hit a new 52-week high during mid-day trading on Wednesday. The company traded as high as $107.80 and last traded at $107.5850, with a volume of 353,609 shares changing hands. The stock had previously closed at $102.03.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on HQY shares. Deutsche Bank Aktiengesellschaft raised their price target on shares of HealthEquity from $135.00 to $142.00 and gave the company a “buy” rating in a research report on Monday, August 31st. BMO Capital Markets boosted their price objective on HealthEquity from $105.00 to $125.00 and gave the stock an “outperform” rating in a report on Wednesday, October 21st. Weiss Ratings raised HealthEquity from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday. Raymond James Financial reissued a “strong-buy” rating on shares of HealthEquity in a research note on Thursday, September 3rd. Finally, Telsey Advisory Group set a $111.00 target price on HealthEquity in a report on Friday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and a consensus price target of $113.53.

HealthEquity Stock Performance

The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.99 and a current ratio of 2.99. The stock has a market cap of $8.58 billion, a P/E ratio of 37.57, a price-to-earnings-growth ratio of 1.72 and a beta of 0.22. The company’s 50 day moving average price is $95.32 and its 200-day moving average price is $89.42.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Thursday, August 27th. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.19 by $0.05. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The company had revenue of $350.73 million during the quarter, compared to the consensus estimate of $349.22 million. The company’s quarterly revenue was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Equities analysts forecast that HealthEquity, Inc. will post 3.94 EPS for the current fiscal year.

Insider Activity at HealthEquity

In other news, Director Adrian Dillon sold 7,632 shares of the business’s stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the transaction, the director owned 62,395 shares in the company, valued at $6,527,140.95. The trade was a 10.90% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.60% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Leonteq Securities AG lifted its stake in HealthEquity by 159.9% in the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after purchasing an additional 235 shares in the last quarter. Axiom Investment Management LLC bought a new position in HealthEquity in the 1st quarter valued at $33,000. Silvant Capital Management LLC purchased a new position in shares of HealthEquity during the 2nd quarter valued at $35,000. Public Employees Retirement System of Ohio purchased a new position in shares of HealthEquity during the 2nd quarter valued at $39,000. Finally, International Assets Investment Management LLC grew its position in shares of HealthEquity by 18,333.3% during the 1st quarter. International Assets Investment Management LLC now owns 553 shares of the company’s stock valued at $46,000 after purchasing an additional 550 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company’s offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits.